Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ishikawa

Showing results (341-350 of 404) with videos related to

Pageof 41
Sort By:
Anticancer Research|September 27, 2015
Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of LifeHitoshi Ishikawa, Hiroyuki Katoh, Takuya Kaminuma, et al.
Anticancer Research|May 31, 2024
Significance of MUC1 and β-Catenin Localization in Mucinous Carcinoma of the BreastKei Sugawara-Komatsu, Takaaki Fujii, Sasagu Kurozumi, et al.
Brachytherapy|December 21, 2004
CT-fluoroscopy guided interstitial brachytherapy with image-based treatment planning for unresectable locally recurrent rectal carcinomaHideyuki Sakurai, Norio Mitsuhashi, Koichi Harashima, et al.
Surgical Case Reports|February 3, 2022
Salvage thoracoscopic esophagectomy after carbon-ion radiotherapy in a patient with esophageal squamous cell carcinoma: a case reportKengo Kuriyama, Makoto Sohda, Hideyuki Saito, et al.
Journal of Radiation Research|April 10, 2023
Analysis of particle therapy registries based on a unified treatment policy for esophageal cancerSunao Tokumaru, Hitoshi Ishikawa, Toshinori Soejima, et al.
Cancers|July 8, 2020
Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study GroupMotohiro Murakami, Hitoshi Ishikawa, Shosei Shimizu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2008
Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancerTomo Suga, Mayumi Iwakawa, Hiroshi Tsuji, et al.
Journal of Radiation Research|May 13, 2024
Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trialMotohiro Murakami, Hitoshi Ishikawa, Yuta Sekino, et al.
Journal of Radiation Research|March 7, 2025
Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG)Toshiya Maebayashi, Takashi Mizowaki, Hitoshi Ishikawa, et al.
Medical Physics|February 10, 2026
Comparison of supine and upright postures in carbon ion radiotherapy for pancreatic cancer: An in silico planning studyYusuke Nomura, Taku Inaniwa, Tetsuro Isozaki, et al.
Pageof 41

Showing results (341-350 of 404) with videos related to

Sort By:
Pageof 41
Anticancer Research|September 27, 2015
Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of LifeHitoshi Ishikawa, Hiroyuki Katoh, Takuya Kaminuma, et al.
Anticancer Research|May 31, 2024
Significance of MUC1 and β-Catenin Localization in Mucinous Carcinoma of the BreastKei Sugawara-Komatsu, Takaaki Fujii, Sasagu Kurozumi, et al.
Brachytherapy|December 21, 2004
CT-fluoroscopy guided interstitial brachytherapy with image-based treatment planning for unresectable locally recurrent rectal carcinomaHideyuki Sakurai, Norio Mitsuhashi, Koichi Harashima, et al.
Surgical Case Reports|February 3, 2022
Salvage thoracoscopic esophagectomy after carbon-ion radiotherapy in a patient with esophageal squamous cell carcinoma: a case reportKengo Kuriyama, Makoto Sohda, Hideyuki Saito, et al.
Journal of Radiation Research|April 10, 2023
Analysis of particle therapy registries based on a unified treatment policy for esophageal cancerSunao Tokumaru, Hitoshi Ishikawa, Toshinori Soejima, et al.
Cancers|July 8, 2020
Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study GroupMotohiro Murakami, Hitoshi Ishikawa, Shosei Shimizu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2008
Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancerTomo Suga, Mayumi Iwakawa, Hiroshi Tsuji, et al.
Journal of Radiation Research|May 13, 2024
Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trialMotohiro Murakami, Hitoshi Ishikawa, Yuta Sekino, et al.
Journal of Radiation Research|March 7, 2025
Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG)Toshiya Maebayashi, Takashi Mizowaki, Hitoshi Ishikawa, et al.
Medical Physics|February 10, 2026
Comparison of supine and upright postures in carbon ion radiotherapy for pancreatic cancer: An in silico planning studyYusuke Nomura, Taku Inaniwa, Tetsuro Isozaki, et al.
Pageof 41